VectivBio AG is a clinical-stage biotechnology company focused on transformational therapeutics for rare diseases, spun out from Therachon in 2019. The company draws on the expertise of its founders to build a portfolio of rare disease medicines while advancing apraglutide for Short Bowel Syndrome.

Products, services, technology

Apraglutide for Short Bowel Syndrome.

Location

Aeschenvorstadt 41, 4051 Basel, Switzerland

Facts & figures
  • Type of organization
    Private company
  • Year of foundation
    2019
  • Number of employees in Switzerland
    10-19
Key business